Abstract
Recurrent pregnancy loss or RPL is defined as a failure of two or more clinical pregnancies [1]. The incidence of RPL is estimated to be <5% with about 1 % of reproductive aged women facing three or more consecutive miscarriages. The major etiopathogenesis of RPL is idiopathic in almost 50% of cases while others include anatomic, genetic, autoimmune, endocrine and infections. When the evaluation of the patient in the above known factors is completed, the lesser known factors such as inflammation and coagulation are considered [2]. In many developing countries, anecdotal treatment of idiopathic causes are instituted without any actual evidence of inflammation. Hence, this commentary is focussed towards the role of mediators of inflammation in patients with recurrent miscarriages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
